Consistent with previous findings, the inhibition of GPAT activity using two pan-GPAT inhibitors, N-ethylmaleimide (NEM) 21 and FSG67 22, significantly decreased intracellular TAG levels and improved apoptosis and sorafenib sensitivity in SR HCC cells (Figure 7A-D). This evidence concerns the gene GPAM and hepatocellular carcinoma.